汉邦高科 (300449.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−34.8x

Market Cap

CNY 2.66B

MomentumView details →

1D Return

−2.13%

YTD Return

−7.48%

RSI (14)

48.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−34.8x

Market Cap

CNY 2.66B

RSI (14)

48.1

MomentumView details →

1D Return

−2.13%

YTD Return

−7.48%

ProfitabilityView details →

Gross Margin

14.58%

Net Margin

−50.89%

EBITDA Margin

−50.67%

ROE (TTM)

−27.90%

ROA (TTM)

−17.46%

Asset Turnover

0.35x

GrowthView details →

Revenue YoY

−13.50%

EPS YoY

−6.98%

FCF YoY

+57.04%

Revenue CAGR 3Y

+9.42%

EPS CAGR 3Y

−25.00%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.22x

Current Ratio

1.87x

Quick Ratio

1.79x

Div Yield

—

Div Rate

—

Div Growth 1Y

+216.20%

Financials snapshotView financials →

Revenue (TTM)

152.52M

Net Income (TTM)

−77.62M

Op. CF (TTM)

−45.41M

Latest newsMore news →

Hanbang Gaoke announced its first-half 2026 results: revenue of 74.8476 million yuan, down 8.46% year-on-year, and a net loss attributable to shareholders of 17.5359 million yuan, compared with a loss of 28.5267 million yuan in the same period of 2025.10d ago

Similar companies

三雄极光300625.SZ 正海生物300653.SZ 安纳达002136.SZ 海欣食品002702.SZ 光华股份001333.SZ 爱朋医疗300753.SZ Find similar companies →

Latest newsMore news →

Hanbang Gaoke announced its first-half 2026 results: revenue of 74.8476 million yuan, down 8.46% year-on-year, and a net loss attributable to shareholders of 17.5359 million yuan, compared with a loss of 28.5267 million yuan in the same period of 2025.10d ago